CollabRx partners with The College of American Pathologists Partners to Provide Personalized Decision Tools to Cancer Patients

The College of American Pathologists (CAP) announced today its partnership with CollabRx to provide patients with advanced stage lung or skin cancer access to the cutting-edge information on cancer therapies that could change their lives. Patients can now download the CollabRx Targeted Therapy Finder apps through the College’s website, and their patient portal,, to find the latest information on diagnostic tests, clinical trials, and approved and emerging cancer therapies.

Connect With Us
Join other physicians who are receiving our updates.
We hate spam. Your email address will not be sold or shared with anyone else.